To investigate the risk of adverse cardiometabolic outcomes in men with a sister diagnosed with PCOS using a large longitudinal population-based cohort of over 1 million individuals.
Key Findings:
Men with a sister with PCOS had an increased risk of obesity (aHR: 2.02, 95% CI: 1.85-2.21), type 2 diabetes (aHR: 1.62, 95% CI: 1.34-1.96), and hypertension (aHR: 1.24, 95% CI: 1.08-1.43) compared to men with unaffected sisters.
In the subcohort, having a sister with PCOS was associated with being overweight (aOR: 1.33, 95% CI: 1.19-1.49) and obese (aOR: 1.78, 95% CI: 1.47-2.15), but not with elevated blood pressure.
Interpretation:
The study indicates that having a sister with PCOS is linked to adverse cardiometabolic outcomes in men, suggesting a familial risk that warrants early screening and prevention strategies in clinical practice.
Limitations:
The study relies on diagnostic codes for PCOS, which may not capture all cases, particularly milder forms.
Potential confounding factors, such as lifestyle and environmental influences, were not accounted for in the analysis.
Conclusion:
The findings highlight the need for awareness of cardiometabolic risks in males with sisters diagnosed with PCOS, emphasizing the importance of early intervention and public health strategies.
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
